APP and Alzheimer disease: Reduction of amyloid-β pathology has been observed in APP (amyloid precursor protein)/PS1 (presenilin) transgenic AD mice in the absence of intestinal microbiota, which indicates a potential role of gut microbiota in the pathogenesis of AD [5].